Aileron Therapeutics Inc (NQ: ALRN )
0.5500 USD -0.0299 (-5.16%) Official Closing Price Updated: 4:06 PM EST, Dec 6, 2021 Add to My Watchlist
All news about Aileron Therapeutics Inc
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 01, 2021
Gainers Hoth Therapeutics (NASDAQ:HOTH) shares moved upwards by 6.08% to $0.86 during Wednesday's after-market session. The company's ...
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 23, 2021
Gainers Biolase (NASDAQ:BIOL) shares increased by 25.69% to $0.53 during Tuesday's after-market session. Today's trading volume for ...
Aileron Therapeutics Announces Presentation of New Preclinical Data at Upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2021
September 30, 2021
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 17, 2021
Gainers Corvus Pharmaceuticals (NASDAQ:CRVS) stock moved upwards by 53.98% to $3.48 during Friday's pre-market ...
Aileron Therapeutics Inc(NASDAQ: ALRN)presented new clinical dataat the European Society of Medical Oncology ...
Aileron Therapeutics Presents New Clinical Data at ESMO Virtual Congress 2021 Supporting ALRN-6924’s Best-in-Class Potential as a Chemoprotective Agent
September 16, 2021
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 14, 2021
Gainers Progenity (NASDAQ:PROG) stock rose 20.19% to $1.13 during Tuesday's pre-market session. The company's ...
The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs
September 12, 2021
Biotech stocks retreated in the holiday-shortened week endingSept. 10, reversing course from the previous week. Humanigen, Inc. ...
Aileron Therapeutics to Present New Clinical Data at ESMO Virtual Congress 2021 Supporting Novel, Selective Chemoprotective Agent ALRN-6924
September 10, 2021
Aileron Therapeutics to Present at Upcoming H.C. Wainwright Virtual Global Investment Conference
September 07, 2021
Aileron Unveils Initial Data For Its Chemo Protective Agent
August 27, 2021
Aileron Therapeutics Inc(NASDAQ: ALRN) hasannounced initial findingsfrom its ongoing study of ALRN-6924 in healthy ...
Aileron Therapeutics Presents Initial Findings from Ongoing Healthy Volunteer Study of ALRN-6924 at ISEH 50th Annual Scientific Meeting
August 27, 2021
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug
August 25, 2021
ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
21 Stocks Moving in Wednesday's Pre-Market Session
August 25, 2021
Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) rose 40.1% to $21.43 in pre-market trading after gaining over 11% on ...
The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More
August 22, 2021
Biotech stocks swayed back and forth before ending the week lower. With earnings news dying down and an empty initial public offerings ...
Aileron Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
August 11, 2021
Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2021
July 08, 2021
Aileron Launches Early-Stage Study For Chemoprotective Candidate In Lung Cancer Settings
July 01, 2021
Aileron Therapeutics Inc(NASDAQ: ALRN)has initiated Phase 1b trialof ALRN-6924 as a chemoprotective agent to treat ...
Aileron Therapeutics Announces Initiation of Randomized, Double-Blind, Placebo-Controlled Trial of ALRN-6924 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
July 01, 2021
Aileron Therapeutics to Host KOL Virtual Investor Event Discussing Opportunity for New Paradigm to Protect Cancer Patients from Chemotherapy-Induced Toxicities
May 19, 2021
Aileron Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
May 11, 2021
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Get ready for another busy week of trading as we kick off Monday with a look at the biggest pre-market stock movers for today. The post...
20 Stocks Moving in Monday's Pre-Market Session
May 10, 2021
Gainers Alfi, Inc. (NASDAQ: ALF) shares rose 30.3% to $4.82 in pre-market trading. The company recently appointed Ron Spears as ...
Gainers Immutep (NASDAQ:IMMP) shares rose 46.38% to $3.85 during Thursday's pre-market session. The company's ...
Aileron Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
March 24, 2021
Gainers BioLife Solutions (NASDAQ:BLFS) shares moved upwards by 11.48% to $43.0 during Monday's after-market session. Today's trading ...
Gainers Fulgent Genetics (NASDAQ:FLGT) stock moved upwards by 29.19% to $110.5 during Thursday's after-market session. This ...
Aileron Therapeutics to Present at 2021 H.C. Wainwright Global Life Sciences Conference
March 04, 2021